Help future moms and babies by enrolling into our Benlysta & Pregnancy study.
MotherToBaby is currently enrolling pregnant people in a study examining the use of Benlysta (belimumab) when taken during pregnancy. If you’ve taken Benlysta and are pregnant, you may qualify for this important study. Our study includes:
- 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
- Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
- An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor
“Help us improve the ability for pregnant people and their healthcare providers to make safe treatment decisions by joining our Benlysta & Pregnancy study.”— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies
If you have lupus and are pregnant, you may qualify to join this important study.
Join our Benlysta Study
Your information is confidential.
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).